(Q38165140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Steatosis in the liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

David Q-H Wang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Brent A Neuschwander-Tetri

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

published in

Comprehensive Physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1493-1532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

Role of the gut in lipid homeostasis

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Overproduction of large VLDL particles is driven by increased liver fat content in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Glycine N -methyltransferase deficiency: a new patient with a novel mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

PPAR delta: a dagger in the heart of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Transcriptional corepression by SHP: molecular mechanisms and physiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

SXR, a novel steroid and xenobiotic-sensing nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The assembly of lipid droplets and its relation to cellular insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Metabolic disturbances in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

PPARdelta is a very low-density lipoprotein sensor in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Phosphatidylcholine biosynthesis and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Enzymes of triacylglycerol synthesis and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

In vivo regulation of SREBP-1c in skeletal muscle: effects of nutritional status, glucose, insulin, and leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Selective taste of ethanol-induced autophagy for mitochondria and lipid droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Re-wiring the circuit: mitochondria as a pharmacological target in liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulation of lipid droplets by autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipid droplets in lipogenesis and lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Disruption of the Saccharomyces cerevisiae homologue to the murine fatty acid transport protein impairs uptake and growth on long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Sex differences in the pharmacokinetics of pioglitazone in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Saturated with fat: new perspectives on lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

CIDE proteins and metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Biochemical mechanisms in drug-induced liver injury: certainties and doubts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Severe liver steatosis correlates with nitrosative and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Expanding roles for lipid droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The role of lipid droplets in metabolic disease in rodents and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

How fatty acids bind to proteins: the inside story from protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

New insights into the roles of proteins and lipids in membrane transport of fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Loss of small heterodimer partner expression in the liver protects against dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Genetic determinants of hepatic steatosis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

SREBPs: transcriptional mediators of lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Intestinal lipid absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

FSP27 promotes lipid droplet clustering and then fusion to regulate triglyceride accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adiponectin and its receptors in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Fat-specific protein 27 regulates storage of triacylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipid phase fatty acid flip-flop, is it fast enough for cellular transport?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Postprandial metabolism of meal triglyceride in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Connecting lipid droplet biology and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Structure and function of the atypical orphan nuclear receptor small heterodimer partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The epidemiology, pathogenesis and histopathology of fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Control of cholesterol biosynthesis, uptake and storage in hepatocytes by Cideb

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Phosphatidylcholine and choline homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma: Implications of the gender disparity in liver cancer susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adiponutrin: A new gene regulated by energy balance in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nuclear receptors in nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

S-adenosylmethionine in liver health, injury, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The murine perilipin gene: the lipid droplet-associated perilipins derive from tissue-specific, mRNA splice variants and define a gene family of ancient origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Farnesoid X receptor is essential for normal glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The role of bile salts in digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The biogenesis of chylomicrons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

S-adenosylmethionine and proliferation: new pathways, new targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Methionine metabolism and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The nuclear receptor LXR is a glucose sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The digestion of dietary triacylglycerols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Glycine N-methyltransferase deficiency: a novel inborn error causing persistent isolated hypermethioninaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Visceral fat and liver fat are independent predictors of metabolic risk factors in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Pathophysiology guided treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Splanchnic lipolysis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Intestinal absorption of long-chain fatty acids: evidence and uncertainties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipid droplets as dynamic organelles connecting storage and efflux of lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of the liver in the control of carbohydrate and lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cidea is associated with lipid droplets and insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Disordered lipid metabolism and the pathogenesis of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipotoxicity: when tissues overeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Insulin sensitivity: modulation by nutrients and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Role of LXRs in control of lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Fatty acid transport across the cell membrane: regulation by fatty acid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adipogenic transcriptional regulation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Structuring food emulsions in the gastrointestinal tract to modify lipid digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipophagy: connecting autophagy and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Autophagy regulates lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Identification of the major intestinal fatty acid transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Abnormal hepatic energy homeostasis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Overexpression of nuclear receptor SHP in adipose tissues affects diet-induced obesity and adaptive thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

CAR and PXR: the xenobiotic-sensing receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Up-regulation of mitochondrial activity and acquirement of brown adipose tissue-like property in the white adipose tissue of fsp27 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The effect of intracellular pH on long-chain fatty acid uptake in 3T3-L1 adipocytes: evidence that uptake involves the passive diffusion of protonated long-chain fatty acids across the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Combined loss of orphan receptors PXR and CAR heightens sensitivity to toxic bile acids in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lipid accumulation in non-adipose tissue and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappaBp65/mTOR-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulation of intestinal cholesterol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc1-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Molecular pathophysiology and physical chemistry of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Regulation of chylomicron production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Which CIDE are you on? Apoptosis and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cell biology: Another way to get rid of fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Liver X receptors as integrators of metabolic and inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cidea promotes hepatic steatosis by sensing dietary fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Cidea-deficient mice have lean phenotype and are resistant to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH?

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Fatty acid transport: the diffusion mechanism in model and biological membranes

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Altered autophagy in human adipose tissues in obesity

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Fatty acid regulation of very low density lipoprotein production

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A.

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP)

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

PPARalpha in the pathogenesis of fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Formation and transport of chylomicrons by enterocytes to the lymphatics

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCPHY.C130001

7 January 2021

Identifiers

DOI

10.1002/CPHY.C130001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24265237%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference